OCTAGON CAPITAL ADVISORS LP Intra-Cellular Therapies, Inc. Transaction History

OCTAGON CAPITAL ADVISORS LP portfolio value:

$10.28M
portfolio value

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 220.95K shares 10.28M $46.53 220.95K